History | Daratumumab monotherapy for treating relapsed and refractory multiple myeloma | Guidance | NICE

History

Expected publication

Equality Impact Assessment (Guidance development) (PDF 143 KB)

Published:

13 April 2022

Final draft guidance

Final draft guidance
Final appraisal document (PDF 281 KB)

Published:

15 March 2022
Committee papers (PDF 2.52 MB)

Published:

13 April 2022
Public committee slides (PDF 1.08 MB)

Published:

13 April 2022

Invitation to participate

Equality impact assessment (Scoping) (PDF 168 KB)

Published:

13 September 2021
Final stakeholder list (PDF 185 KB)

Published:

13 September 2021
Final scope (PDF 207 KB)

Published:

13 September 2021